Novo Nordisk A/S

Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
May 11, 2025
Tens of thousands of Americans will soon be forced by their heath insurance to switch from one popular obesity drug to another that produces less weight loss.It is the...
Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy
February 5, 2025
Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, capped off a somewhat turbulent 2024, reporting profit and revenue on Wednesday that comfortably beat Wall Street expectations. But...